90% of Drug Promotion Shifted to Remote Tools; Prudent Attitude Needed for New Launches amid COVID-19: IQVIA Official

Japan’s pharma industry sees promotional activity shift from face-to-face to remote methods and companies should be prudent in new drug launches, including possible postponements, amid the COVID-19 outbreak, Alan Thomas, director of Thought Leadership at IQVIA Japan Group, said on...read more